Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 28, 2002
Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available dataStaffan Edsbäcker, Ralph Brattsand
Pulmonary Pharmacology & Therapeutics|September 30, 2022
May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?Ralph Brattsand, Olof Selroos
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Budesonide Attains Its Wide Clinical Profile by Alternative KineticsRalph Brattsand, Olof Selroos
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|September 24, 2024
Inhaled budesonide and pulmonary sarcoidosis revisitedOlof Selroos, Ralph Brattsand
Clinical Therapeutics|December 4, 2003
The role of intracellular esterification in budesonide once-daily dosing and airway selectivityRalph Brattsand, Anna Miller-Larsson
Annals of Clinical Biochemistry|July 21, 2017
20α- and 20β-dihydrocortisone may interfere in LC-MS/MS determination of cortisol in saliva and urineMarlen Israelsson, Ralph Brattsand, Göran Brattsand
Drugs|September 25, 2019
Benefit:Risk Profile of Budesonide in Obstructive Airways DiseaseDonald P Tashkin, Brian Lipworth, Ralph Brattsand
Drugs|November 7, 2019
Correction to: Benefit:Risk Profile of Budesonide in Obstructive Airways DiseaseDonald P Tashkin, Brian Lipworth, Ralph Brattsand
Journal of Medicinal Chemistry|July 25, 2003
Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis modelMalin Graffner-Nordberg, Meredith Fyfe, Ralph Brattsand, et al.
The Journal of Allergy and Clinical Immunology|January 19, 2002
Molecular mechanisms of decreased steroid responsiveness induced by latent adenoviral infection in allergic lung inflammationKatsuhiko Yamada, W Mark Elliott, Ralph Brattsand, et al.
Pageof 1